Purchase Order 36C24425P0090

Award Date 11/13/24
Potential Completion Date 5/13/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Butler, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award, with a ceiling value of $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, a Delivery Order under a larger Federal Supply Schedule (FSS) contract, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy products and associated support services. These include Optune...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducer devices, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma in veteran patients. The award is part of a larger $28.85 million Federal...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with the company's Optune Plus transducer arrays, device rentals, and associated support services for the treatment of glioblastoma and mesothelioma. The contract, valued at $49,748.73, is a delivery order issued under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA....
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a delivery order under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices,...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is a delivery order under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services for the treatment of...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's Optune Plus system, which delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. This is a firm-fixed-price purchase order with a period of performance running through...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm-fixed-price delivery order was awarded under Novocure's existing $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides Optune Plus transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma using...

This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract has a firm fixed price and an ultimate completion date of May 13, 2025. Novocure acts as the prime contractor, delivering its Optune TTFields therapy products and services directly to various VA medical centers nationwide without the use of subcontractors. The contract is not set aside and is issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at a ceiling of $28.85 million and awarded in November 2022. This FSS contract provides a streamlined procurement mechanism for the VA to efficiently acquire Novocure's innovative cancer treatment technologies, supporting the agency's mission of expanding veterans' access to cutting-edge therapies.

Generated 11/15/24, 9:13 AM